News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,597 Results
Type
Article (40637)
Company Profile (254)
Press Release (656706)
Section
Business (204919)
Career Advice (2101)
Deals (35528)
Drug Delivery (94)
Drug Development (81524)
Employer Resources (169)
FDA (16218)
Job Trends (14907)
News (346640)
Policy (32707)
Tag
Academia (2588)
Alliances (49731)
Alzheimer's disease (1323)
Approvals (16199)
Artificial intelligence (213)
Bankruptcy (357)
Best Places to Work (11693)
Biotechnology (182)
Breast cancer (235)
Cancer (1790)
Cardiovascular disease (134)
Career advice (1746)
CAR-T (130)
Cell therapy (377)
Clinical research (65675)
Collaboration (689)
Compensation (376)
COVID-19 (2603)
C-suite (171)
Data (1684)
Diabetes (218)
Diagnostics (6360)
Earnings (85737)
Employer resources (145)
Events (111624)
Executive appointments (588)
FDA (17161)
Funding (618)
Gene therapy (263)
GLP-1 (661)
Government (4409)
Healthcare (18907)
Infectious disease (2719)
Inflammatory bowel disease (127)
Interviews (343)
IPO (16514)
Job creations (3648)
Job search strategy (1481)
Layoffs (446)
Legal (7936)
Lung cancer (263)
Manufacturing (244)
Medical device (13293)
Medtech (13298)
Mergers & acquisitions (19401)
Metabolic disorders (566)
Neuroscience (1744)
NextGen: Class of 2025 (6563)
Non-profit (4526)
Northern California (2169)
Obesity (312)
Opinion (204)
Patents (175)
People (57131)
Phase I (20491)
Phase II (28930)
Phase III (21529)
Pipeline (772)
Postmarket research (2570)
Preclinical (8711)
Radiopharmaceuticals (245)
Rare diseases (333)
Real estate (5917)
Regulatory (22122)
Research institute (2356)
Resumes & cover letters (355)
Southern California (1862)
Startups (3598)
United States (19135)
Vaccines (633)
Weight loss (213)
Date
Last 7 days (804)
Last 30 days (2600)
Last 365 days (34466)
2025 (5267)
2024 (35458)
2023 (40299)
2022 (51455)
2021 (55956)
2020 (54304)
2019 (46841)
2018 (35295)
2017 (32361)
2016 (31691)
2015 (37756)
2014 (31495)
2013 (26535)
2012 (28732)
2011 (29445)
2010 (27456)
Location
Africa (731)
Arizona (213)
Asia (37919)
Australia (6216)
California (4952)
Canada (1754)
China (409)
Colorado (227)
Connecticut (235)
Europe (81660)
Florida (729)
Georgia (172)
Illinois (463)
Indiana (270)
Maryland (756)
Massachusetts (3771)
Michigan (200)
Minnesota (341)
New Jersey (1404)
New York (1415)
North Carolina (860)
Northern California (2169)
Ohio (174)
Pennsylvania (1135)
South America (1110)
Southern California (1862)
Texas (726)
Utah (154)
Washington State (477)
697,597 Results for "express scripts inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
September 17, 2024
·
2 min read
·
Kate Goodwin
BioMidwest
Express Scripts enhances strategies to support access to care at independent pharmacies
Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.
May 23, 2024
·
3 min read
Pharm Country
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
Phathom Pharmaceuticals, Inc. today announced the placement of VOQUEZNA® (vonoprazan) tablets for the treatment of adults with Erosive Esophagitis, commonly referred to as Erosive GERD (gastroesophageal reflux disease), and relief of heartburn associated with Erosive Esophagitis on the Express Scripts national formularies, effective immediately.
February 13, 2024
·
11 min read
Lone Star Bio
INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients
Lexicon Pharmaceuticals, Inc. announced that Express Scripts, the pharmacy benefits management business of The Cigna Group’s Evernorth, has determined that it will place INPEFA on its Premier Access and Premier Performance national formularies for Medicare patients on November 1, 2023.
October 9, 2023
·
9 min read
Lone Star Bio
INPEFA® (Sotagliflozin) Receives Coverage From Express Scripts on Its Basic and High Performance Formularies for Commercially Insured Patients
Lexicon Pharmaceuticals, Inc. announced that Express Scripts, the pharmacy benefits management business of The Cigna Group’s Evernorth, has determined that it will place INPEFA on its Basic and High Performance formularies for commercially insured patients as of, November 1, 2023, and in addition to the previously reported Premier Access and Premier Performance national formularies for Medicare patients.
November 1, 2023
·
9 min read
Press Releases
Celltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab on their medical benefit formulary
August 29, 2024
·
11 min read
BioMidwest
Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Express Scripts announced that as part of its commitment to driving greater affordability for clients and people living with inflammatory conditions, it will add three additional biosimilars to its National Preferred Formulary.
July 10, 2023
·
4 min read
Press Releases
Gene Expression Market Projected to Touch USD 25.26 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production: MoU Signed Between EVA Pharma, DNA Script, Quantoom Biosciences
February 5, 2025
·
8 min read
Biotech Beach
Arcutis’ ZORYVE® (Roflumilast) Cream 0.3% Added to Express Scripts, Inc.® National Formularies in the United States
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that ZORYVE® (roflumilast) cream 0.3% for the treatment of plaque psoriasis in adults and adolescents is now on Express Scripts national formularies for commercial benefit plans, effective November 18.
November 17, 2022
·
4 min read
1 of 69,760
Next
